Diakoneo Klinik Hallerwiese-Cnopfsche Kinderklinik
- Address
- St.-Johannis-Mühlgasse 19, 90419 Nuremberg, Germany
ALK-positive Anaplastic Large Cell Lymphoma (ALCL)
The pediatric hematology‑oncology unit at Diakoneo Klinik Hallerwiese-Cnopfsche Kinderklinik is evaluating a new approach for children with standard risk ALK-positive anaplastic large cell lymphoma. The trial tests whether a 24‑month course of Vinblastine monotherapy can raise cure rates to at least 75 % in this patient group.
- Vinblastine monotherapy in children
- Standard‑risk patient stratification
- Long‑term survival outcomes
- Pediatric oncology therapeutic advances
This research highlights the site’s commitment to improving treatment options for rare pediatric cancers and contributes valuable data to international oncology collaborations.
Stage IV Childhood Renal Tumour
A second study at the same department investigates newly diagnosed stage IV childhood renal tumour with both pulmonary and non‑pulmonary metastases. Researchers compare pre‑operative six‑week courses of VCE versus VAD to assess non‑inferiority in the overall metastatic rapid response rate, including separate pulmonary and non‑pulmonary response measures.
- Pre‑operative chemotherapy regimens
- Metastatic rapid response evaluation
- Pulmonary and non‑pulmonary metastasis outcomes
- SIOP RANDOMET 2017 protocol implementation
By focusing on response rates in high‑risk renal tumours, the trial aims to refine treatment pathways and enhance survival prospects for affected children.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1GPOH gGmbH3active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1GPOH gGmbH3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diakoneo Klinik Hallerwiese-Cnopfsche Kinderklinik
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine | GPOH gGmbH | Phase III | Recruiting | Feb 2020 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Etoposide | 3 | Unknown | 2019-08-02 | 2022-06-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.